India wants Serum Institute to lower price of AstraZeneca shot, say sources
Monday, 11 January 2021 () The Indian government has been negotiating with the Serum Institute of India to bring down the price of AstraZeneca's Covid-19 vaccine, delaying the roll-out of the country's immunisation programme. Senior officials have been discussing the terms of the deal with the Serum Institute for weeks, hoping to bring down prices below $3 per shot, one of the sources with direct knowledge told Reuters.
The Government of India announced the launch date of its mass immunisation programme against Covid-19. The vaccinations will begin on January 16, 2021. On January 3, India's drug regulator DCGI had cleared 2 vaccines - Covaxin and Covishield - for emergency use. Covaxin, made by Bharat Biotech, will...
Germany has said the Oxford/AstraZeneca vaccine should not be offered to people over the age of 65, a source close to the country's government has told Sky News. Sky News
Michael Gove says that the UK’s supply of Covid-19 vaccines for the future has been assured amid threats from the European Union of vaccine export controls on AstraZeneca doses leaving the bloc. Report by Jonesia. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
Sri Lanka's president on Thursday welcomed the first 500,000 doses of a Covid-19 vaccine from India, which has donated the shots to eight countries in the.. IndiaTimes
Nepal launched Covid-19 immunisation after India sent vaccines. India sent 10 lakh doses of Covishield vaccines to Nepal as a gift. Nepal PM Oli thanked India and PM Modi for the vaccine consignment. The Serum Institute of India has tied up with AstraZeneca to manufacture Covishield. Thousands of Nepalese frontline workers are set to be vaccinated. Nepal PM said talks are on with India to get more vaccines at a proper price. Oli said, “We got an early chance to administer the Covid-19 vaccine. For this, I thank our neighbouring nation India, its government, the people, and especially Prime Minister Narendra Modi. They sent 10 lakh doses of vaccines to us as a grant within a week of the roll-out in India.” Meanwhile, China is yet to get clearance for its Sinopharm vaccine in Nepal. Nepal has had over 2.7 lakh total covid cases and over 2,000 deaths. Watch the full video for more.
Credit: HT Digital Content Duration: 03:11Published
India once again established its position as a reliable partner in Covid-19 assistance. It dispatched Covishield to Bahrain and Sri Lanka under the Vaccine Maitri Initiative. Sri Lanka to receive a consignment of 50,400 doses, while Bahrain to get 10,800 doses. Covishield developed by Serum Institute of India was loaded to cargo aircraft at Mumbai. The cargo aircraft left Mumbai airport as per schedule at 7:55 am for Manama. The vaccine consignment for Colombo, which delayed for 15 minutes, left at 9:00 am. Meanwhile, India has supplied vaccines to its neighbours under neighbourhood first policy. Bhutan, Maldives, Nepal, Myanmar, Sri Lanka, Afghanistan, Bangladesh received vaccines. India sees international cooperation in the area of fight against Covid-19 as its duty. New Delhi has played the role of the first responder in the region.
Credit: HT Digital Content Duration: 01:29Published
Serum Institute of India's vaccine consignment arrived at Mumbai's Chhatrapati Shivaji Maharaj International Airport on January 28. The consignment containing COVID-19 vaccine will be dispatched to Bahrain and Colombo today. India is helping other countries with the import of COVID vaccine amid the pandemic.
Prime Minister Narendra Modi said India will soon make available many more covid-19 vaccines to other countries. He also highlighted India's success in the fight against Covid-19. PM Modi said that he wants to assured global business community that the situation will now change rapidly. “Many more India-made vaccines will soon be made available to the world. India's upcoming vaccines will help other countries to fight pandemic at swifter pace. I want to assure global business community that situation will now change rapidly,” he said. The prime minister was addressing the World Economic Forum's online Davos agenda summit.
Credit: HT Digital Content Duration: 03:51Published
Prime Minister Boris Johnson visits a Covid-19 vaccine centre in Glasgow. Report by Jonesia. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
Portugal's epidemic has entered a "terrible" phase, Prime Minister Antonio Costa has admitted, and the surge in cases has left hospitals on the brink of collapse. Emily Wither reports.
Prime Minister Boris Johnson visits the Lighthouse Laboratory at the Queen Elizabeth University Hospital campus in Glasgow, where coronavirus tests are processed. Report by Jonesia. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
Nepal on Wednesday began its nationwide inoculation drive after receiving one million Covishield vaccines, manufactured by the Serum Institute of India (SII), from the Indian government last week...
Serum Institute of India (SII) CEO Adar Poonawalla on January 22 informed that there is no impact of fire on the production of 'Covishield' vaccine. "The extent of the damage is more than 1,000 crores...
A blaze engulfed a building at Serum Institute of India, killing 5 people. Serum Institute is responsible for the production of the vital Covishield vaccine the production of which has not been..
Even as the country’s first indigenous Covid-19 vaccine Covaxin has received Emergency Use Authorisation (EUA) from the country’s drug regulatory... IndiaTimes Also reported by •Zee News •Hindu
The expert panel is likely to approve the vaccine developed by AstraZeneca and Oxford University for emergency use on Friday, Reuters reported quoting sources.... IndiaTimes Also reported by •Mid-Day •Hindu
The BJP on Sunday hit out at the Congress after some of its leaders questioned the approval process for Bharat Biotech's Covid-19 vaccine, with party president J... IndiaTimes